Related Experiment Video
Updated: Aug 11, 2025

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
Anti-cancer activity of ultra-short single-stranded polydeoxyribonucleotides
Alexander S Vedenkin1, Sergey V Stovbun2, Alexander A Bukhvostov3
1N.N. Semenov Federal Research Center for Chemical Physics RAS, Moscow, Russia. a.s.vedenkin@gmail.com.
Abstract:
One of the features that differentiate cancer cells is their increased proliferation rate, which creates an opportunity for general anti-tumor therapy directed against the elevated activity of replicative apparatus in tumor cells. Besides DNA synthesis, successful genome replication requires the reparation of the newly synthesized DNA. Malfunctions in reparation can cause fatal injuries in the genome and cell death. Recently we have found that the ultra-short single-stranded deoxyribose polynucleotides of random sequence (ssDNA) effectively inhibit the catalytic activity of DNA polymerase [Formula: see text]. This effect allowed considering these substances as potential anti-tumor drugs, which was confirmed experimentally both in vitro (using cancer cell cultures) and in vivo (using cancer models in mice). According to the obtained results, ssDNA significantly suppresses cancer development and tumor growth, allowing consideration of them as novel candidates for anti-cancer drugs.
Insights
Ultra-short single-stranded deoxyribose polynucleotides (ssDNA) show promise as novel anti-cancer drugs. These compounds effectively inhibit DNA polymerase, suppressing cancer cell proliferation and tumor growth in preclinical studies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Cancer cells exhibit increased proliferation rates, presenting a therapeutic target.
- DNA replication and repair are critical for cell survival and proliferation.
- Inhibiting DNA replication machinery can lead to cancer cell death.
Purpose of the Study:
- To investigate the anti-tumor potential of ultra-short single-stranded deoxyribose polynucleotides (ssDNA).
- To evaluate the efficacy of ssDNA in inhibiting DNA polymerase activity.
- To assess the therapeutic effects of ssDNA on cancer development and tumor growth.
Main Methods:
- In vitro studies using cancer cell cultures.
- In vivo studies using mouse cancer models.
- Assay of DNA polymerase catalytic activity inhibition by ssDNA.
Main Results:
- ssDNA effectively inhibits the catalytic activity of DNA polymerase.
- ssDNA demonstrated significant suppression of cancer development in vitro.
- ssDNA significantly suppressed tumor growth in vivo mouse models.
Conclusions:
- Ultra-short single-stranded deoxyribose polynucleotides are effective inhibitors of DNA polymerase.
- ssDNA exhibits significant anti-tumor activity, warranting further investigation as a novel cancer therapeutic agent.
More Related Videos
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
Single-Strand DNA Binding Proteins